Despite the fact that vaccines against COVID have already undergone strict safety reviews and that people continue to die ...

Vaccine opponents and skeptics in charge of federal health agencies are restricting access to COVID shots that were a signature accomplishment of President Donald Trump’s first term.

The advisory committee meeting comes days after the FDA unveiled a new risk-based approval framework for COVID-19 vaccines.

The vaccine expert talks about what this could mean for the fall, whether more safety studies are really needed and what ...

In a significant policy shift, the FDA has decided to halt the blanket recommendation for annual boosters for healthy individuals under 65, specifically urging a more cautious approach. FDA ...

The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being ...

Despite an explanation of the new strategy published Tuesday from FDA Commissioner Marty Makary and Vinay Prasad, who ...

The FDA had given Pfizer and Moderna until May 17 to propose changes to the labels of their COVID-19 vaccines or challenge ...

FDA COVID vaccine update is stirring major public attention as a new policy limits fall COVID-19 booster shots to seniors and ...

The Trump administration's new COVID-19 vaccine plan limits access to high-risk groups, requiring further trials for low-risk individuals, marking a major policy shift amid scientific uncertainty and ...

The truth is that for most of that, for many Americans, we simply do not know the answer to whether or not they should be ...

Senior Biden Food and Drug Administration (FDA) officials spent weeks casting doubt on reports of cardiac risks associated ...